c.460+1G>A
SpliceS2PathogenicCytoplasmic · predictedS2 — Predicted frameshift skip of exon 4 (145 nt)
Interactive 3D Structure
AlphaFold wild-type wolframin · the variant site near residue 154 (N-terminal cytoplasmic (intrinsically disordered)) is highlighted.
Variant Assessment
Therapeutic Implication · S2
Clinical Evidence
Observed at very low frequency in gnomAD.
Feed this card to Wolfram Intelligence
Download the c.460+1G>A card below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals matched to this S2 splice variant and its domain context.
Full Variant Card
c.460+1G_A — WFS1 Molecular Atlas Card
Variant type: Splice site Boundary: donor (5' splice site) · intronic offset +1 Nearest protein position: ~154 (N-terminal cytoplasmic (intrinsically disordered))
Schema category: S2 — Predicted frameshift skip of exon 4 (145 nt)
SpliceAI predicts strong donor (5') loss (ΔS 1.00) -> skipping of exon 4 (145 nt, NOT divisible by 3), which shifts the reading frame downstream. A premature stop is predicted at ~aa 115. The frameshifted/truncated product follows the frameshift schema (F1/F2 by NMD); typically too compromised for chaperone rescue — gene-therapy track. (acceptor-gain 0.00, acceptor-loss 0.00, donor-gain 0.96, donor-loss 1.00.)
Splice prediction
- Affected site: donor (5' splice site), canonical (±1/±2 core)
- SpliceAI delta scores (GRCh38 chr4:6289132 G>A):
- acceptor gain 0.00 · acceptor loss 0.00
- donor gain 0.96 · donor loss 1.00
- Predicted outcome: Predicted frameshift skip of exon 4 (145 nt)
Clinical evidence
- Classification: Pathogenic
- Review status: criteria provided, multiple submitters, no conflicts
- cDNA change: c.460+1G>A
- ClinVar accession: VCV000004515
- Last evaluated: 2024/10/23 00:00
- Submissions: 1
Card generated by wolfram-atlas-batch (splice pipeline) on 2026-06-08T07:50:33.326616Z.
Schema: reference/card_schema_extension.md (S1–S3). WFS1: UniProt O76024, AlphaFold v6.